Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?
作者信息
Orvieto Raoul
机构信息
Infertility and IVF Unit, Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat Gan, Israel.
Sackler Faculty of Medicine, Aviv University, Tel Aviv, Israel.
出版信息
J Assist Reprod Genet. 2016 Oct;33(10):1415-1416. doi: 10.1007/s10815-016-0775-4. Epub 2016 Jul 22.
Abstract
摘要
相似文献
1
Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?触发最终卵泡成熟——人绒毛膜促性腺激素、促性腺激素释放激素激动剂或两者兼用，何时使用以及用于何人？
J Assist Reprod Genet. 2016 Oct;33(10):1415-1416. doi: 10.1007/s10815-016-0775-4. Epub 2016 Jul 22.
2
Basic understanding of gonadotropin-releasing hormone-agonist triggering.促性腺激素释放激素激动剂扳机的基本认识。
Fertil Steril. 2015 Apr;103(4):867-9. doi: 10.1016/j.fertnstert.2014.12.129. Epub 2015 Feb 21.
3
The prevention of ovarian hyperstimulation syndrome.卵巢过度刺激综合征的预防
J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5.
4
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.在促性腺激素释放激素拮抗剂治疗的卵母细胞捐赠周期中使用人绒毛膜促性腺激素或促性腺激素释放激素激动剂进行触发：一项大型回顾性队列研究的结果
Fertil Steril. 2009 Feb;91(2):365-71. doi: 10.1016/j.fertnstert.2007.11.049. Epub 2008 Mar 25.
5
Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.在多囊卵泡发育病例中，低剂量人绒毛膜促性腺激素用于GnRH激动剂触发排卵后黄体支持的安全性和有效性。
Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. doi: 10.1016/j.ejogrb.2005.11.013. Epub 2005 Dec 22.
6
Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?触发卵泡最终成熟——人绒毛膜促性腺激素、促性腺激素释放激素激动剂还是两者并用，何时使用以及适用于何人？
J Ovarian Res. 2015 Aug 21;8:60. doi: 10.1186/s13048-015-0187-6.
7
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.对于有卵巢过度刺激综合征风险且正在接受控制性卵巢刺激的患者，采用促性腺激素释放激素激动剂触发排卵并积极进行黄体期支持。
Taiwan J Obstet Gynecol. 2015 Oct;54(5):583-7. doi: 10.1016/j.tjog.2015.08.012.
8
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization.在体外受精的卵巢过度刺激过程中，在与GnRH拮抗剂加尼瑞克联合治疗后，使用GnRH激动剂触发最终卵母细胞成熟后的内分泌情况。
J Clin Endocrinol Metab. 2002 Feb;87(2):709-15. doi: 10.1210/jcem.87.2.8197.
9
Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates.采用 GnRH 激动剂联合小剂量 hCG 黄体支持进行卵母细胞成熟，可在维持优异妊娠率的同时，最大限度降低卵巢过度刺激综合征的严重程度。
Hum Reprod. 2011 Dec;26(12):3437-42. doi: 10.1093/humrep/der333. Epub 2011 Oct 13.
10
Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.评估促性腺激素释放激素激动剂亮丙瑞林触发卵母细胞成熟的充分性和处理反应不足。
Fertil Steril. 2016 Oct;106(5):1093-1100.e3. doi: 10.1016/j.fertnstert.2016.06.013. Epub 2016 Jun 21.
引用本文的文献
1
Triggering final follicular maturation for IVF cycles.触发体外受精周期的最终卵泡成熟。
Reprod Biol Endocrinol. 2025 Jan 23;23(Suppl 1):12. doi: 10.1186/s12958-024-01332-5.
2
From accepting oversight to being overlooked: the devilish details of controlled ovarian stimulation.从接受监督到被忽视：控制性卵巢刺激的棘手细节
J Assist Reprod Genet. 2021 Sep;38(9):2225-2226. doi: 10.1007/s10815-021-02333-8.
3
Low dose hCG supplementation in a Gn-RH-agonist trigger protocol is associated with worse pregnancy outcomes: a retrospective cohort study.在促性腺激素释放激素激动剂扳机方案中补充低剂量人绒毛膜促性腺激素与更差的妊娠结局相关：一项回顾性队列研究。
Fertil Res Pract. 2021 May 28;7(1):12. doi: 10.1186/s40738-021-00104-8.
4
5
Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT.比较促性腺激素释放激素激动剂与人绒毛膜促性腺激素对接受宫内人工授精的不孕女性最终用于排卵触发的卵母细胞的影响：一项随机对照试验。
Int J Reprod Biomed. 2017 Jun;15(6):351-356.
本文引用的文献
1
GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.与单独使用促性腺激素释放激素（GnRH）激动剂相比，联合使用低剂量人绒毛膜促性腺激素（hCG）（双重触发）的GnRH激动剂会增加严重卵巢过度刺激综合征的风险。
J Assist Reprod Genet. 2016 Sep;33(9):1175-84. doi: 10.1007/s10815-016-0755-8. Epub 2016 Jun 27.
2
A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.一种简化的体外受精促排卵方案通用方法：采用定制的最终卵泡成熟模式和时间的超短激动剂/拮抗剂联合方案。
J Ovarian Res. 2015 Nov 4;8:69. doi: 10.1186/s13048-015-0198-3.
3
Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?触发卵泡最终成熟——人绒毛膜促性腺激素、促性腺激素释放激素激动剂还是两者并用，何时使用以及适用于何人？
J Ovarian Res. 2015 Aug 21;8:60. doi: 10.1186/s13048-015-0187-6.
4
Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.对于成熟卵母细胞比例较低的患者，联合使用促性腺激素释放激素激动剂（GnRH-agonist）和人绒毛膜促性腺激素（hCG）进行最终卵母细胞成熟（双重触发）。
Gynecol Endocrinol. 2015 Feb;31(2):145-7. doi: 10.3109/09513590.2014.978850. Epub 2014 Nov 11.
5
Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles--a preliminary report.在每个排卵前卵泡中获取的卵母细胞数量较少的患者中，联合使用促性腺激素释放激素激动剂（GnRH-agonist）和人绒毛膜促性腺激素（hCG）进行最终卵母细胞成熟（双重触发）——初步报告。
J Ovarian Res. 2014 Aug 2;7:77. doi: 10.1186/1757-2215-7-77.
6
HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.在使用促性腺激素释放激素激动剂触发最终卵泡成熟后，于取卵后第3天给予人绒毛膜促性腺激素（1500国际单位），可使黄体中期孕酮水平足够高——这是一个概念验证。
J Ovarian Res. 2014 Apr 3;7:35. doi: 10.1186/1757-2215-7-35.
7
Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.卵巢过度刺激综合征——未解之谜的最佳解决方案。
J Ovarian Res. 2013 Nov 5;6(1):77. doi: 10.1186/1757-2215-6-77.
8
Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos.卵巢过度刺激综合征的预测。挑战雌二醇神话。
Hum Reprod. 2003 Apr;18(4):665-7. doi: 10.1093/humrep/deg166.
9
Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient.一名低促性腺激素性性腺功能减退患者，尽管血浆雌激素浓度较低，但仍发生了严重的卵巢过度刺激综合征。
Hum Reprod. 1996 Jun;11(6):1177-9. doi: 10.1093/oxfordjournals.humrep.a019350.
10
Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome.复发性自发性卵巢过度刺激综合征与多囊卵巢综合征相关。
Gynecol Endocrinol. 1995 Dec;9(4):313-5. doi: 10.3109/09513599509160465.
Zotero 插件